Article
Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX: A GeT-RM Collaborative Project.
The Journal of molecular diagnostics : JMD - 1 Aug 2021
Pratt Victoria M, Turner Amy, Broeckel Ulrich, Dawson D Brian, Gaedigk Andrea, Lynnes Ty C, Medeiros Elizabeth B, Moyer Ann M, Requesens Deborah, Vetrini Francesco, Kalman Lisa V
Abstract excerpt
Pharmacogenetic testing is increasingly available from clinical and research laboratories. However, only a limited number of quality control and other reference materials are currently available for many of the variants that are tested. The Association for Molecular Pathology Pharmacogenetic Work Group has published a series of papers recommending alleles for inclusion in clinical testing. Several of the alleles...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.